ASX 200 set to fall – APT, Z1P & WOW shares in focus
Drew Meredith, CFP
June 21, 2021
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday
The ResMed CDI (ASX: RMD) share price is in the
There are some quality ASX tech shares that Aussies can
The ResMed Inc (ASX:RMD) share price is on watch this
Here are 3 of my top ethical ETFs for Australian
ResMed CDI (ASX:RMD) shares have a long history of outperformance
The S&P/ASX 200 (ASX: XJO) is expected to trade higher
The S&P/ASX 200 (INDEXASX: XJO) is expected to edge lower
The ResMed Inc (ASX:RMD) profit jumped 40% in its FY20
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
By downloading, you agree to receive emails from us. You can unsubscribe anytime.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.